In this study, we established T24/DDP&GEM cells resistant to cisplatin and gemcitabine, and investigated the regulation role of BMI1/miR-3682-3p/P-GP axis in T24/DDP&GEM cells and in bladder cancer tissues of patients resistant to GC chemotherapy. This evidence concerns the gene BMI1 and urinary bladder cancer.